GLP-1 medications mimic a natural hormone that regulates appetite and blood sugar. They slow gastric emptying, reduce hunger signals to the brain, and help you feel full longer. Tirzepatide also targets the GIP receptor, adding a second mechanism that improves insulin sensitivity. Result: significant calorie reduction without constant willpower battles.

About 10 minutes east on I-90 — take it to Exit 296 in Liberty Lake.

Semaglutide targets the GLP-1 receptor and produces 15–17% body weight loss on average over 68 weeks of treatment (STEP trials). Tirzepatide targets BOTH GLP-1 and GIP receptors, producing 20–22% average body weight loss (SURMOUNT trials) — and provides stronger insulin sensitivity benefit. Dr. Belkoff helps each patient choose the right option based on labs, goals, and history.

For Spokane Valley patients, compounded semaglutide is $175/month and tirzepatide is $250/month. Both include the medication, comprehensive baseline labs, body composition analysis, unlimited messaging and telehealth, and unlimited in-office check-ins with Dr. Belkoff — no hidden fees, contracts, or enrollment charges.

Clinical studies show average weight loss of 15–17% with semaglutide and 20–22% (sometimes more) with tirzepatide over 12–18 months. Individual results depend on starting weight, adherence, dose titration, and lifestyle factors. Most patients also see improvements in energy, sleep, blood pressure, cholesterol, and joint pain.

Used under physician supervision, GLP-1 medications have a well-established safety profile. The most common side effect is mild nausea during the first few weeks of dose titration, which usually settles within 2–4 weeks. Every Spokane Valley patient is monitored by Dr. Belkoff with regular lab work, and dosing is adjusted to keep side effects minimal.

Your first visit — a short drive east of Spokane Valley to our Liberty Lake clinic, or by telehealth — is a one-on-one consultation with Dr. Belkoff, DO. He reviews your medical history, current medications, and weight loss goals, orders a comprehensive metabolic blood panel, performs a body composition analysis, and outlines your plan. It's free, with no commitment to start.

No rigid diet required. GLP-1 medications work on their own, but pairing them with sensible nutrition and regular movement improves results and helps Spokane Valley patients keep the weight off long-term. Dr. Belkoff provides personalized nutrition guidance — sustainable habits, not extremes.

Either. Your first visit can be in person or virtual, and follow-ups can be done by telehealth across Washington and Idaho.

Most patients see optimal results over 6–12 months. Once you reach your target weight, Dr. Belkoff develops a personalized maintenance plan — which may include tapering medication, transitioning to a lower maintenance dose, or focusing on lifestyle and metabolic health to maintain results long-term. The plan is designed around your individual response and goals, not a template.

Ozempic and Wegovy are brand-name semaglutide from Novo Nordisk. The compounded semaglutide we provide is the same active ingredient, prepared by a licensed 503A pharmacy under physician prescription — usually more affordable and easier to access during brand shortages. Spokane Valley patients can also request brand-name Ozempic, Wegovy, Mounjaro, or Zepbound.

Most insurance plans do not cover GLP-1 medications for weight loss without a type 2 diabetes diagnosis, and even then coverage varies. That's why our membership is flat-rate cash pricing — no insurance hoops, no surprise bills, no prior authorizations. Patients with HSA/FSA accounts can typically use those funds.

Most side effects are mild and dose-dependent: nausea, fatigue, constipation, and mild GI upset, especially during dose increases. They typically resolve within days as your body adapts. Serious side effects are rare. Because we titrate slowly under physician supervision and adjust dosing based on tolerance, most patients experience minimal issues. Patients with personal/family history of medullary thyroid carcinoma or MEN2 syndrome are not candidates.

Many patients report decreased alcohol cravings and tolerance on GLP-1 medications — this is one of the most-discussed effects. Moderate alcohol is generally okay, but it can worsen nausea, slow weight loss, and stress the liver. We recommend patients minimize or eliminate alcohol during the active weight loss phase for best results.

Prime Body Solutions is located in Liberty Lake, WA — a 15-minute drive from downtown Spokane and just across the state line from Post Falls and Coeur d'Alene, ID. We serve patients throughout the Inland Northwest with both in-person and telehealth options. Dr. Cody Belkoff, DO is the supervising physician for every patient.

Patients who quit GLP-1 therapy abruptly without lifestyle changes tend to regain some weight. That's why our Spokane Valley program pairs medication with nutrition, strength training, and metabolic optimization — so when you taper or stop, your habits and metabolism hold the result. Some patients move to a low maintenance or microdosing protocol with Dr. Belkoff.